Compression fracture
Conditions
Interventions
Electroacupuncture Group:The patient will be in a prone position and receive electroacupuncture treatment of BL23, BL25, BL40, BL60, GV20, KI3 and GB34. Deqi will connect the electroacupuncture device
Medication Group:1. Alendronate: 70mg per week, fasted overnight, taken with water in the morning after waking up.
2. Salmon calcitonin: 200 International Units (IU) or 1 spray into one nostril per da
Sponsors
Zhaoqing medical college
Eligibility
Sex/Gender
Female
Age
49 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Menopausal women aged 49-70 years. 2. sign an informed consent form. 3. meet the diagnostic criteria for primary thoracolumbar osteoporotic compression fracture: (1) Medical history: risk factors: smoking, alcohol consumption, oestrogen deficiency, dietary calcium or vitamin D deficiency, Asian, advanced age, etc. (2) Physical examination: closed fist percussion along the spine, sudden and sharp pain felt by the patient, pain when the patient rotates the body, etc. (3) Imaging: edema on sagittal T2-weighted magnetic resonance (MR) images or on a short inversion recovery sequence combined with a sagittal T1-weighted sequence. (4) Ancillary examinations: Bone mineral density measured by dual-energy X-ray absorptiometry (DXA) with a T value = -2.5 SD. 4. A1 fractures in the AOSpine classification of thoracolumbar spine injuries, compression injuries, wedge compression or embedment fractures with a single endplate fracture, not involving the posterior wall of the vertebral body. 5. Thoracolumbar spine injury classification and severity (TLICS) score = 4.
Exclusion criteria
Exclusion criteria: 1. Unstable compression fractures that should be treated by surgery. 2. With severe scoliosis with a Cobb angle > 30°. 3. With combination of other systemic diseases leading to secondary osteoporosis 4. Suffering from severe allergic, infectious skin diseases. 5. Suffering from bleeding disorders (e.g. thrombocytopenic purpura, haemophilia, etc.) 6. Suffering from severe cognitive impairment and unable to cooperate with treatment. 7. Requiring long-term oral medication that affects bone metabolism, such as glucocorticoids 8. With neurological complications. 9. Having a metal implant in the body, such as a pacemaker.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone mineral density;Visual analogue scoring; | — |
Secondary
| Measure | Time frame |
|---|---|
| Oswestry dysfunction index;QUALEFFO-41; | — |
Countries
China
Contacts
Public ContactHuang Yong
Southern Medical University College of Traditional Chinese Medicine
Outcome results
None listed